IDXX Stock Overview
Develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
IDXX passed our risk checks.
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$430.30 |
| 52 Week High | US$535.60 |
| 52 Week Low | US$359.10 |
| Beta | 1.33 |
| 11 Month Change | -4.38% |
| 3 Month Change | -6.09% |
| 1 Year Change | 4.19% |
| 33 Year Change | -22.02% |
| 5 Year Change | 69.61% |
| Change since IPO | 196.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| IDXX | AT Medical Equipment | AT Market | |
|---|---|---|---|
| 7D | -1.7% | -0.4% | 0.5% |
| 1Y | 4.2% | 20.5% | 5.6% |
Return vs Industry: IDXX underperformed the Austrian Medical Equipment industry which returned 21% over the past year.
Return vs Market: IDXX underperformed the Austrian Market which returned 5.6% over the past year.
Price Volatility
| IDXX volatility | |
|---|---|
| IDXX Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.1% |
| 10% least volatile stocks in AT Market | 2.0% |
Stable Share Price: IDXX has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: IDXX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| IDXX fundamental statistics | |
|---|---|
| Market cap | €35.73b |
| Earnings (TTM) | €773.50m |
| Revenue (TTM) | €3.46b |
46.1x
P/E Ratio10.3x
P/S RatioIs IDXX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDXX income statement (TTM) | |
|---|---|
| Revenue | US$3.78b |
| Cost of Revenue | US$1.50b |
| Gross Profit | US$2.29b |
| Other Expenses | US$1.44b |
| Earnings | US$845.63m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 31, 2024
| Earnings per share (EPS) | 10.27 |
| Gross Margin | 60.41% |
| Net Profit Margin | 22.34% |
| Debt/Equity Ratio | 59.8% |
How did IDXX perform over the long term?
See historical performance and comparison